Terry Dagnon - 20 Apr 2023 Form 4 Insider Report for Outlook Therapeutics, Inc. (OTLK)

Role
Chief Operations Officer
Signature
/s/ Lawrence Kenyon, Attorney-in-Fact
Issuer symbol
OTLK
Transactions as of
20 Apr 2023
Net transactions value
-$590,200
Form type
4
Filing time
21 Apr 2023, 21:05:47 UTC
Previous filing
19 Apr 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OTLK Common Stock Sale $590,200 -520,000 -44% $1.14 653,058 20 Apr 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were sold to cover taxes upon lapse of Issuer's repurchase right as to 75% of the shares as provided in that certain Consulting Agreement dated January 27, 2020.